About 80 million Americans fill prescriptions each year for medications to treat new instances of moderate to severe pain, ...
The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...
Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
The drug offers a non-addictive alternative to opioids, marking 'an important public health milestone in acute pain ...
A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...
It wasn’t until the first time that I saw someone else with vitiligo in person that my perception changed. This stranger didn’t seem to have a care in the world about his spots. He seemed so ...
Warning over popular medication. Picture ... research is now needed to confirm our findings, given its minimal pain-relief effect, the use of paracetamol as a first-line pain killer for long ...
(The Center Square) – The U.S. Food and Drug Administration has revoked authorization for Red No. 3 in food and ingested drugs in response to a 2022 color additive petition. Safety concerns ...